Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rennie Rhee, MD
University of Pennsylvania
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Healthcare Hamilton
Hamilton, Ontario, Canada
Not, yet, recruiting
- University Hospital Wuerzburg
Würzburg, Würzburg, Germany
Not, yet, recruiting
- Mayo Building and Gonda Building
Rochester, Minnesota, United States
Recruiting - 3400 Civic Center Blvd
Philadelphia, Pennsylvania, United States
Rennie Rhee, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jul 2020
- Primary completion
- 31 Jul 2030
- Completion
- 31 Jul 2033
- Last update posted
- 19 Sept 2025
- Registered enrollment
- 400
- Registry id
- NCT05865054
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.